Christopher Laudani is the founder and president of, a short-only equity research firm.

The third-largest U.S. telecom has a lot on the line for investors.
Until this new management team can deliver higher than single-digit top-line growth, I'll hold off on recommending the stock.
Here's why shares of the cosmetics retailer are likely not done going down.
The fruits of its five-year plan are going straight to the bottom line.
Bulls think the grocer's stock is cheap, but the upside appears limited based on anticipated earnings.
This may be the quarter where the cloud comes together for the company, which could see its stock rise if it is.
The deal with SolarCity is due to close at the end of the year, but wait for better entry point.
I have been a big bull on its technology, but I am sidelined right now.
The EpiPen controversy makes this stock a shot in the dark.
Fiber-optics maker's shares are up some 270% since May's IPO.


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.